PostEra
PrivateLast Round
Grant
May 18, 2022
Total Funding Raised
$94.5M
Company Overview
PostEra is a biotechnology company that offers an AI-driven drug discovery platform that uses machine learning to accelerate medicinal chemistry and optimize small molecule development.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, ML Platforms
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PostEra Comparables
Compare PostEra with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Genesis Molecular AI | 90% | |
| Iktos | 86% | |
| Terray Therapeutics | 85% | |
PostEra Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 18, 2022 | ||||
| Series A | Jan 11, 2022 | ||||
| Seed | Mar 30, 2020 |
Key People
Founding team and executive leadership
PostEra Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Breyer Capital | Series A |
| I2BF Global Ventures | Series A |
| Pioneer Fund | Series A, Seed |
| Metaplanet Holdings | Series A, Seed |
| NIH RADx | Grant |
| Lifeforce Capital | Series A |
| Pioneer Fund | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 11, 2022
$24M round led by The Clermont Group.
PostEra Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about PostEra's valuation, stock price, and market status.